Synthesis and biological evaluation of N-(4-phenylthiazol-2-yl)cinnamamide derivatives as novel potential anti-tumor agents†
Abstract
In this study, a series of novel
* Corresponding authors
a
Sichuan University, State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy and Cancer Center, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China
E-mail:
yuluot@scu.edu.cn
Fax: +86 28 8516 4060
Tel: +86 28 8516 4063
b Department of Pharmaceutical and Bioengineering, School of Chemical Engineering, Sichuan University, Chengdu, Sichuan 610065, China
c College of Chemistry and Life Science, Chengdu Normal University, Chengdu 611130, China
d Department of Encephalopathy, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan University of Traditional Chinese Medicine, Zhengzhou, China
e Wisdom Pharmaceutical Co. Ltd, Haimen, China
In this study, a series of novel
Y. Luo, Y. Zhu, K. Ran, Z. Liu, N. Wang, Q. Feng, J. Zeng, L. Zhang, B. He, T. Ye, S. Zhu, X. Qiu and L. Yu, Med. Chem. Commun., 2015, 6, 1036 DOI: 10.1039/C4MD00573B
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content